Effective, Wednesday, April 1, 1998, all interested parties can call the following number to order FDA IND, NDA, ANDA and Drug Master File binders:


            U.S. Government Printing Office (GPO)
            Washington, DC 20404-0001
            (202) 512-1800

            Program #B511-S

Quantity of binders that can be order at any one time is to be determined by GPO.

 


REQUIREDSPECIFICATIONS FOR FDA's
IND, NDA, ANDA, DRUG MASTER FILE BINDERS

As of June 10, 1997, FDA no longer provides IND, NDA, ANDA or Drug Master Files application binders to outside firms - Firms are required to have their own binders made and printed according to the following specifications - If you have any questions or need additional information, please contact Mia Prather at 301-796-0618.


POLYETHYLENE BINDERS -

Front (flat size) - 248 x 292mm (9-3/4 x 11-1/2")
Back (flat size) - 248 x 305mm (9-3/4 x 12") (size includes 13 mm (1/2") lip at top)

Must be high impact linear plastic (matte finish or similar) - Must be able to withstand temperatures up to 150 degrees - Material should have a surface smooth enough to allow printing with a complete bonding of ink to the surface after a minimum of one hour drying time - Should be free from streaks, blisters, scratches and mottling -

Binder weight MUST be .023-.025 gauge - Ink color MUST be BLACK -

Polyethylene Binders include -


PAPER BINDERS -

Front (flat size) - 267 x 292mm (10-1/2 x 11-1/2")
Back (flat size) - 267 x 305mm (10-1/2 x 12") (size includes 13mm (1/2") lip at top)

Binder MUST be of 11-point plate rope stock of extra heavy weight - Ink color MUST be BLACK - Maroon binder ink color MUST be WHITE -

Paper Binders include -

PRINTING - Required on front folder in a clear, sharp, permanent-type print in BLACK ink - Permanent adhesive labels may be used in a clear, sharp print - Printing must withstand a "Scotch Tape Test" which consists of pressing a strip of "Scotch" tape firmly on the printed area and removing - There should be NO transfer of the printed area on the tape -

BINDING - POLYETHYLENE binders (front and back) MUST contain an internal (HIDDEN) hinge formed in the material by heat and pressure - Hinge should extend along the entire left-hand binding edge of the binder and be of a depth to provide a clean straight fold free from wrinkle when created or folded on the hinge - Hinge holes should be reinforced with metal eyelets and suitable for accommodating an ACCO-type fastener allowing for expansion - Outside binder surfaces MUST be smooth with NO exposed hinges or fastener -

PAPER binders (front and back) MUST have 2 hinge holes scored along the entire left-hand binding edge and must be of a depth to provide a clean straight fold free from wrinkle when creased or folded on the score - Hinge holes should be reinforced and suitable for accommodating an ACCO-type fastener allowing for expansion -

Round corner the inside edge of tab on back folder and outside edges of the front and back folders on polyethylene and paper binders -

Finished margins MUST conform with binder sizes indicated above -

Below is a cover sample for FDA Form 2626, 2626a thru h - NDA Applications

Below is a cover sample for FDA Form 2675, 2675a and b - IND Appications

Below is a cover sample for FDA Form 3316, 3316a - Drug Master Files

 


SPECIFICATIONS Page 2

 

 

SAMPLE COVER - FORM FDA 2626 (series a-h)

 

NOTE: Sample is SMALLER in print (FONT) size than actual cover. Printing MUST match lay-out of previously submitted section binders.

 

VOLUME __________________

 

 

NEW DRUG APPLICATION

 

NDA No. _________

 

 

NAME OF APPLICANT

 

 

NAME OF NEW DRUG

 

 

 

SECTION NAME (* see below) 

 

This submission: VOL.______OF______VOLS. 

 

 

Listed below are FDA New Drug Application (NDA) / Abbreviated New Drug Application (ANDA) binders identical to sample above. Section cover name is ONLY difference.

 

* FORM # COLOR INK SECTION COVER NAME
2626 Blue Black ARCHIVAL COPY
2626a Red Black NDA CHEMISTRY
2626b Yellow Black NDA PHARMACOLOGY
2626c Orange Black NDA PHARMACOKINETIC
2626d White Black NDA MICROBIOLOGY
2626e Tan Black NDA CLINICAL DATA
2626f Green Black NDA STATISTICS
2626h Maroon White NDA FIELD SUBMISSION CHEMISTRY

SPECIFICATIONS Page 3

 

SAMPLE COVER - FORM FDA 2675 (series a-b)

 

Note: Sample is smaller in print (FONT) size than actual cover. Printing MUST match lay-out of previously submitted section binders.

 

VOLUME __________________

 

 

NOTICE OF CLAIMED

 

INVESTIGATIONAL 

 

EXEMPTION FOR A 

 

NEW DRUG

 

 

IND. NO.__________

 

 

SPONSOR 

 

 

NAME OF DRUG (* see below)

 

 

This submission: VOL._____OF______VOLS.

 

 

Listed below are FDA Investigational New Drug (IND) binders identical to sample above. Section cover name is ONLY difference.
* FORM # COLOR INK COVER DRUG NAME
2675 Red Black IND NAME OF DRUG
2675a Green Black IND NAME OF DRUG
2675b Orange Black IND NAME OF DRUG

 

 


SPECIFICATIONS Page 4

 

 

SAMPLE COVER - FDA FORM 3316

 

NOTE: Sample is SMALLER in print (FONT) size than actual cover. Printing MUST match lay-out of previously submitted section binders.

 

 

VOLUME __________________

 

 

DRUG MASTER FILE

 

NO. ________

 

 

NAME OF APPLICANT

(* see below)

 

TYPE:

 

This submission: VOL.______OF______VOLS.

 

 

Listed below are FDA Drug Master File (DMF) binders identical to sample above. File # and Type will be ONLY difference.
* FORM # COLOR INK COVER NAME
3316 Red Black Drug Master File
3316a Blue Black Drug Master File